PRELUDE CAPITAL MANAGEMENT, LLC
Position in VYGR — Voyager Therapeutics, Inc.
CIK 1387508
NEW YORK, NY
Position in VYGR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$59,892
-$756 QoQ
Shares Held
17,112
+8.9% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 135 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $43,640,056 across 72 Biotechnology names. VYGR ranks #63 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,590 | $7,776,650 | |
| 2 | TECH |
BIO-TECHNE Corp
|
91,696 | $6,478,322 | |
| 3 | PGEN |
Precigen, Inc.
|
882,267 | $5,028,921 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
113,104 | $4,002,750 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,997 | $2,059,518 | |
| 6 | TWST |
Twist Bioscience Corp
|
18,976 | $1,952,250 | |
| 7 | QURE |
uniQure N.V.
|
32,229 | $1,484,467 | |
| 8 | MDXG |
Mimedx Group, Inc.
|
215,239 | $828,670 |
All Filings in VYGR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,892 | 17,112 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $60,648 | 15,712 | Shares | Other | 2026-05-15 | |
| 2025-03-31 | $87,261 | 25,817 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $100,926 | 17,800 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $120,510 | 20,600 | Shares | Other | 2024-11-14 | |
| 2023-09-30 | $90,791 | 11,715 | Shares | Other | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||